Oxaltero 100mg Injection Specification
- Usage
- Treatment of colon and rectal cancer.
- Salt Composition
- Oxaliplatin
- Expiration Date
- 2028 Years
- Molecular Formula
- Oxaliplatin
- Medicine Type
- Anti cancer
- Indication
- Treatment of colon and rectal cancer.
- Pacakaging (Quantity Per Box)
- 1
- Storage
- Store at a temperature below 30 C.
Oxaltero 100mg Injection Trade Information
- Minimum Order Quantity
- 5 Pieces
About Oxaltero 100mg Injection
Oxaltero 100mg Injection contains Oxaliplatin, a platinum-based chemotherapy medication used in combination with other anticancer drugs to treat stage III colon cancer after surgical removal of the primary tumor, as well as advanced or metastatic colorectal cancer affecting the colon and rectum. It works by damaging the DNA of cancer cells, preventing their growth and multiplication, and is particularly effective against certain tumors that may be resistant to cisplatin-based treatments. Colorectal cancer develops due to the accumulation of genetic mutations influenced by both hereditary and environmental factors, leading to uncontrolled cell growth in the large intestine or rectum. Common side effects of Oxaltero 100mg Injection may include low blood cell counts, nausea, vomiting, diarrhea, indigestion, heartburn, throat discomfort, blood clots, blood in the urine, high blood pressure, insomnia, depression, and low calcium levels. Patients should inform their healthcare provider if any of these side effects become severe or persistent. Before starting treatment, it is important to disclose any allergies to Oxaliplatin, as well as any history of kidney disease, liver disorders, heart conditions, or current medications and vaccinations. Oxaltero 100mg Injection is generally not recommended during pregnancy or breastfeeding due to potential risks to the developing baby. Regular medical monitoring, including blood tests and organ function assessments, is essential to ensure the safe and effective use of this medication and to achieve the best possible treatment outcomes.